VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy ; volume:23 ; number:1 ; day:7 ; month:11 ; year:2023 ; pages:1-21 ; date:12.2023
Cancer cell international ; 23, Heft 1 (7.11.2023), 1-21, 12.2023
- Creator
-
Shekari, Najibeh
Shanehbandi, Dariush
Kazemi, Tohid
Zarredar, Habib
Baradaran, Behzad
Jalali, Seyed Amir
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-023-03116-0
- URN
-
urn:nbn:de:101:1-2024012409184845597180
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shekari, Najibeh
- Shanehbandi, Dariush
- Kazemi, Tohid
- Zarredar, Habib
- Baradaran, Behzad
- Jalali, Seyed Amir
- SpringerLink (Online service)
Other Objects (12)
IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
CXCR4 ligands: the next big hit?
Natural killer cells: a promising immunotherapy for cancer
Polyimido Sulfur Compounds as Promising Ligands in Molecular Magnets
Promising Lithography Techniques for Next-Generation Logic Devices
The promising alliance of anti-cancer electrochemotherapy with immunotherapy
Exosome-based immunotherapy: a promising approach for cancer treatment
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
BAP31, a promising target for the immunotherapy of malignant melanomas
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
Next-generation immunotherapy to counteract T-cell exhaustion
IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
CXCR4 ligands: the next big hit?
Natural killer cells: a promising immunotherapy for cancer
Polyimido Sulfur Compounds as Promising Ligands in Molecular Magnets
Promising Lithography Techniques for Next-Generation Logic Devices
The promising alliance of anti-cancer electrochemotherapy with immunotherapy
Exosome-based immunotherapy: a promising approach for cancer treatment
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
BAP31, a promising target for the immunotherapy of malignant melanomas
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
Next-generation immunotherapy to counteract T-cell exhaustion
IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
CXCR4 ligands: the next big hit?
Natural killer cells: a promising immunotherapy for cancer
Polyimido Sulfur Compounds as Promising Ligands in Molecular Magnets
Promising Lithography Techniques for Next-Generation Logic Devices
The promising alliance of anti-cancer electrochemotherapy with immunotherapy
Exosome-based immunotherapy: a promising approach for cancer treatment
Telomerase-based vaccines: a promising frontier in cancer immunotherapy
BAP31, a promising target for the immunotherapy of malignant melanomas
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy